Norwegian health industry
Oslo Cancer Cluster promotes the Norwegian health industry through a number of activities. We help budding biotechs to commercialise their ideas in our Incubator and across Norway. We connect Norwegian health companies with international key players. We act as a changemaker, by influencing the framework conditions for cancer innovations in the Norwegian health industry.
The White Paper on the Health Industry in Norway
On 5 April 2019, the Norwegian government published a White Paper on the health industry, for the first time ever. The White Paper addresses the barriers that the health industry faces and describes the government’s political plan to overcome them.
IMPORTANT BACKGROUND DOCUMENTS
For the last four years, Oslo Cancer Cluster has participated in the making of the Menon report. The Menon report describes a health industry that in 2018 alone had a turn-over of over NOK 142 billion. It represents a dual opportunity for Norway. Firstly, it can solve many of the challenges in the health and care sector in the next ten years. Secondly, it can become one of our biggest industries, exporting to a global market.
Read previous reports here (in Norwegian)